Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
ADUS vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
ADUS vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans |
| Market Cap | $1.80B | $333.37B |
| Revenue (TTM) | $1.45B | $449.71B |
| Net Income (TTM) | $100M | $12.04B |
| Gross Margin | 32.5% | 18.8% |
| Operating Margin | 9.8% | 4.2% |
| Forward P/E | 14.0x | 20.1x |
| Total Debt | $209M | $78.39B |
| Cash & Equiv. | $82M | $24.36B |
ADUS vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Addus HomeCare Corp… (ADUS) | 100 | 97.7 | -2.3% |
| UnitedHealth Group … (UNH) | 100 | 120.5 | +20.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ADUS vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ADUS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.58
- Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
- 427.2% 10Y total return vs UNH's 220.3%
UNH is the clearest fit if your priority is dividends and momentum.
- 2.4% yield; 25-year raise streak; the other pay no meaningful dividend
- -4.7% vs ADUS's -11.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.2% revenue growth vs UNH's 11.8% | |
| Value | Lower P/E (14.0x vs 20.1x) | |
| Quality / Margins | 6.9% margin vs UNH's 2.7% | |
| Stability / Safety | Beta 0.58 vs UNH's 0.59, lower leverage | |
| Dividends | 2.4% yield; 25-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -4.7% vs ADUS's -11.0% | |
| Efficiency (ROA) | 7.0% ROA vs UNH's 3.9%, ROIC 8.8% vs 9.2% |
ADUS vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ADUS vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ADUS leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 310.5x ADUS's $1.4B. Profitability is closely matched — net margins range from 6.9% (ADUS) to 2.7% (UNH). On growth, ADUS holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.4B | $449.7B |
| EBITDAEarnings before interest/tax | $159M | $23.2B |
| Net IncomeAfter-tax profit | $100M | $12.0B |
| Free Cash FlowCash after capex | $137M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +32.5% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +9.8% | +4.2% |
| Net MarginNet income ÷ Revenue | +6.9% | +2.7% |
| FCF MarginFCF ÷ Revenue | +9.5% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.7% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +17.2% | +0.7% |
Valuation Metrics
ADUS leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 18.5x trailing earnings, ADUS trades at a 33% valuation discount to UNH's 27.8x P/E. On an enterprise value basis, ADUS's 12.4x EV/EBITDA is more attractive than UNH's 16.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.8B | $333.4B |
| Enterprise ValueMkt cap + debt − cash | $1.9B | $387.4B |
| Trailing P/EPrice ÷ TTM EPS | 18.55x | 27.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.02x | 20.06x |
| PEG RatioP/E ÷ EPS growth rate | 0.92x | — |
| EV / EBITDAEnterprise value multiple | 12.44x | 16.61x |
| Price / SalesMarket cap ÷ Revenue | 1.27x | 0.74x |
| Price / BookPrice ÷ Book value/share | 1.64x | 3.29x |
| Price / FCFMarket cap ÷ FCF | 17.36x | 20.74x |
Profitability & Efficiency
ADUS leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $9 for ADUS. ADUS carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs UNH's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.3% | +11.5% |
| ROA (TTM)Return on assets | +7.0% | +3.9% |
| ROICReturn on invested capital | +8.8% | +9.2% |
| ROCEReturn on capital employed | +10.9% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.19x | 0.77x |
| Net DebtTotal debt minus cash | $127M | $54.0B |
| Cash & Equiv.Liquid assets | $82M | $24.4B |
| Total DebtShort + long-term debt | $209M | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 14.45x | 4.71x |
Total Returns (Dividends Reinvested)
ADUS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ADUS five years ago would be worth $10,257 today (with dividends reinvested), compared to $9,746 for UNH. Over the past 12 months, UNH leads with a -4.7% total return vs ADUS's -11.0%. The 3-year compound annual growth rate (CAGR) favors ADUS at 4.9% vs UNH's -7.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.3% | +9.8% |
| 1-Year ReturnPast 12 months | -11.0% | -4.7% |
| 3-Year ReturnCumulative with dividends | +15.5% | -20.4% |
| 5-Year ReturnCumulative with dividends | +2.6% | -2.5% |
| 10-Year ReturnCumulative with dividends | +427.2% | +220.3% |
| CAGR (3Y)Annualised 3-year return | +4.9% | -7.3% |
Risk & Volatility
Evenly matched — ADUS and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
ADUS is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 90.7% from its 52-week high vs ADUS's 77.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 0.59x |
| 52-Week HighHighest price in past year | $124.44 | $404.72 |
| 52-Week LowLowest price in past year | $90.89 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +77.7% | +90.7% |
| RSI (14)Momentum oscillator 0–100 | 54.6 | 74.5 |
| Avg Volume (50D)Average daily shares traded | 239K | 8.1M |
Analyst Outlook
UNH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ADUS as "Buy" and UNH as "Buy". Consensus price targets imply 33.1% upside for ADUS (target: $129) vs 4.9% for UNH (target: $385). UNH is the only dividend payer here at 2.37% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $128.67 | $385.43 |
| # AnalystsCovering analysts | 15 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% |
| Dividend StreakConsecutive years of raises | 2 | 25 |
| Dividend / ShareAnnual DPS | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.7% |
ADUS leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). UNH leads in 1 (Analyst Outlook). 1 tied.
ADUS vs UNH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ADUS or UNH a better buy right now?
For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.
2% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 5x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Addus HomeCare Corporation (ADUS) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ADUS or UNH?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.
5x versus UnitedHealth Group Incorporated at 27. 8x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 0x.
03Which is the better long-term investment — ADUS or UNH?
Over the past 5 years, Addus HomeCare Corporation (ADUS) delivered a total return of +2.
6%, compared to -2. 5% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: ADUS returned +427. 2% versus UNH's +220. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ADUS or UNH?
By beta (market sensitivity over 5 years), Addus HomeCare Corporation (ADUS) is the lower-risk stock at 0.
58β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 2% more volatile than ADUS relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — ADUS or UNH?
By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.
2% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: Addus HomeCare Corporation grew EPS 23. 2% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, ADUS leads at 14. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ADUS or UNH?
Addus HomeCare Corporation (ADUS) is the more profitable company, earning 6.
7% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 4. 2% for UNH. At the gross margin level — before operating expenses — ADUS leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ADUS or UNH more undervalued right now?
On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14.
0x forward P/E versus 20. 1x for UnitedHealth Group Incorporated — 6. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 33. 1% to $128. 67.
08Which pays a better dividend — ADUS or UNH?
In this comparison, UNH (2.
4% yield) pays a dividend. ADUS does not pay a meaningful dividend and should not be held primarily for income.
09Is ADUS or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +220. 3% 10Y return). Both have compounded well over 10 years (UNH: +220. 3%, ADUS: +427. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ADUS and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ADUS is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while ADUS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.